APRE Stock Analysis: Buy, Sell, or Hold?
APRE - Aprea Therapeutics, Inc. Common stock
$0.72
-0.02 (-3.09%)
▼
5d:
-3.73%
30d:
-4.36%
90d:
-21.25%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 11, 2026
27d
Get Alerted When APRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APRE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APRE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APRE is currently trading at $0.72, which is considered slightly low relative to its 30-day fair value range of $0.72 to $0.79.
Technical Outlook: Technically, APRE is showing sideways momentum. Immediate support is located at $0.69, while resistance sits at $0.82. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: APRE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.30 (+495.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APRE is showing sideways momentum. Immediate support is located at $0.69, while resistance sits at $0.82. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: APRE has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $4.30 (+495.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.72 -
$0.79
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 495.6% below Wall St target ($4.30)
Trading Range Analysis
30-Day Trading Range
$0.72 -
$0.79
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.69
Resistance Level
$0.82
Current Trend
Sideways
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.91
Wall Street Target
$4.30
(+495.6%)
Revenue Growth (YoY)
-98.4%
Share & Embed Analysis
Last updated: July 14, 2026 7:14 AM ET
Data refreshes hourly during market hours. Next update: 8:14 AM
Data refreshes hourly during market hours. Next update: 8:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$36 | 61 BUY |
